Dianthus Therapeutics
73 employees
Biotech/Pharma
Public · $100.0M
Open positions (5)
Company details
Team Size73
IndustryBiotech/Pharma
Funding
Total raised
$100.0M
Last stage
Public
Investors
Fidelity Management & Research Company
Total raised
$100.0M
Last stage
Public
Investors
Tomas Kiselak
Co-founder of Dianthus Therapeutics and Managing Member at Fairmount Funds Management LLC, a healthcare investment firm he co-founded. Previously a managing director at RA Capital Management.
Jonathan Violin
Dr. Violin co-founded Dianthus in July 2019 and has served on the Board of Directors since. He previously co-founded Viridian Therapeutics and Trevena Inc., and served as founding CEO of Quellis Biosciences.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.